Public Shareholders (Euronext Paris, Nasdaq)
Biotech Investor · 2 portfolio companies
Portfolio
2
Combined Value
$1.1B
Focus Areas
5
Top Stage
Commercial
Portfolio Companies
| Company | Valuation |
|---|---|
| Valneva SE | $896.6M |
| Genfit | $240M |
Biotech Investor · 2 portfolio companies
| Company | Valuation |
|---|---|
| Valneva SE | $896.6M |
| Genfit | $240M |